1 / 19

Current epidemiological data indicate that one of five children and adolescents under the age of 18 has a mental health

The Presidential World Psychiatric Association (WPA) Program on Global Child Mental Health Conducted i n Collaboration with The World Health Organization (WHO) & The International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP).

taylor
Download Presentation

Current epidemiological data indicate that one of five children and adolescents under the age of 18 has a mental health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Presidential World Psychiatric Association (WPA)Program on Global Child Mental HealthConducted in Collaboration withThe World Health Organization (WHO)&The International Association for Child and AdolescentPsychiatry and Allied Professions (IACAPAP)

  2. Current epidemiological data indicate that one of five children and adolescents under the age of 18 has a mental health problem. • 3-4% of this age group has a serious mental disorder requiring treatment.

  3. Only a small proportion of children and adolescents affected by mental disorder receive adequate care. • There is lack of awareness of the magnitude and severity of the problems caused by children mental disorders by: - Political decision makers. - Health decision makers. - Health professionals. - General Public.

  4. At present there are only very few countries with clear policies and plans concerning child mental health. • Research on child mental health is poorly supported.

  5. OBJECTIVES OF THE PROGRAM (1): To increase the awareness of health decision-makers, health professionals and the general public about the magnitude and severity of problems related to mental disorders in childhood and adolescence and about possibilities for their resolution.

  6. OBJECTIVES OF THE PROGRAM (2): To promote the application of measures of primary prevention of mental disorders in childhood and adolescence and of interventions that will contribute to the healthy mental development of children and adolescents.

  7. OBJECTIVES OF THE PROGRAM (3): To offer support to the development of services for children and adolescence with mental disorders and to facilitate the use of effective methods of treatment.

  8. PRODUCTS OF THE PROGRAM(1): The publicationof critical reviews of the literature on child and adolescent mental health and of information about relevant programs in different countries. Internationally-accepted guidelines for activities promoting child and adolescent mental health.

  9. PRODUCTS OF THE PROGRAM(2): Manuals and guidelines concerned with the prevention, early recognition, detection and treatment of mental disorders in childhood for health professionals and others concerned with child care and upbringing (e.g. teachers, parents, religious leaders, social welfare workers).

  10. PRODUCTS OF THE PROGRAM(3): • A functional network of individuals and institutions committed to the achievement of the objectives of the program. • A data base containing information about the current epidemiological situation and about policies and programs relevant to the promotion of child mental health in different parts of the world.

  11. TIMETABLE OF THE PROGRAM: (Year 1) 1- The development of critical reviews of information concerning - The promotion of mental health of children and adolescents. - The prevention of mental disorders in childhood. - The organisation of services and treatment of mental disorders in that age.

  12. 2- The establishment of the Child and Adolescent Mental Health Network composed of institutions and advisers. 3- The development of drafts of manuals and guidelines concerned with child mental health and the management of mental disorders in childhood. 4- The establishment of alliances with international and national organizations relevant to the Program’s objectives.

  13. TIMETABLE OF THE PROGRAM: (Year 2) 1- The translation and field testing of the manuals and guidelines. 2- The trial application of comprehensive child mental health programs in selected countries. 3- The preparation of a policy-making conference involving health decision makers as well as experts in the field of mental health and various relevant organizations.

  14. TIMETABLE OF THE PROGRAM: (Year 3) 1- The publication of the finalized manuals and guidelines. 2- Support to the introduction and wide application of manuals at country level. 3- The conduct of a policy conference to present the products of the program and to initiate the development of national child mental health programs.

  15. Members of the Steering Committee: • Chairperson A. Okasha (Egypt) • Vice Chairperson N. Sartorius (Switzerland) • Scientific Director H. Remschmidt (Germany) • Scientific Vice Director S. Tyano (Israel) • Secretary T. Okasha (Egypt) • Members P. Jensen (USA) B. Nurcombe (Australia) • WHO Representative M. Belfer (Geneva) • Eli Lilly Representative J. Heiligenstein (USA)

  16. Task force on Awareness Chairperson: S. Tyano (Israel) Members: M. Belfer (Switzerland) K. M. Hong (Korea) J. Schaller (USA) D. Wasserman (Sweden) C. Hoven (USA) D. Song (China) T. Agoussou (WHO/AFRO)

  17. Task force on Primary Prevention Chairperson: H. Remschmidt (Germany) Members: L. Rohde (Brazil) T. Dmitrieva (Russia) P. Rydelius (Sweden) A. Seif El-Din (Egypt) M. Flament (Canada) E. Caffo (Italy) J. Cox (UK)

  18. Task force on Health Services, Management And Treatment Chairperson: P. Jensen (USA) Members: S. F. Hung (China) J. Fayyad (Lebanon) J. Bauermeister (Puerto Rico) R. Harrington (UK) K. Kelleher (USA) K. Hoagwood (USA)

  19. PROGRAM FUNDING This program is supported by: 1. An unrestricted educational grant from the Eli Lilly and Company Foundation 2. Contributions of institutions and individuals participating in the program.

More Related